Swift Medical raises US$35 million Series B to transform wound care delivery with AI

July 15, 2021

Torys represented Swift Medical with a team that included Cheryl Reicin, Matthew Atkey and Adam Falconi (corporate/life sciences).

On July 15, 2021, Swift Medical announced a US$35 million Series B financing. The investment round was led by Virgo Investment Group LLC (“Virgo”), through one of its managed-investment funds, followed by existing investors DCVC, who led their Series A, and BDC Capital, through their Women in Technology Venture Fund. Other participating investors included leading health technology firms Claritas Capital, Chrysalis Ventures, Pender Ventures and Export Development Canada.

Swift Medical provides an AI-powered, digital wound care platform that allows any patient or clinician to easily capture a high precision image of their wound with their mobile phone, autonomously determines wound dimensions and clinical characteristics, enables virtual wound care consultations and provides real-time, predictive insights to drive enhanced preventive and personalized care.

This latest round of funding will help Swift Medical expand their leading market position and scale their digital wound management platform across the care continuum in North America.

Further information can be found on Business Wire’s website.

Swift Medical is the world leader in digital wound care. Their technology is used by over 4,000 healthcare organizations across the continuum of care to improve the prevention, treatment and management of wounds.